FOX BIZ NEWS: Is Sarepta Therapeutics a Good Gene Therapy Stock to Buy Now?

Is Sarepta Therapeutics a Good Gene Therapy Stock to Buy Now?



It's hard not to get excited about this company's experimental gene therapy for Duchenne muscular dystrophy.